Suppr超能文献

与转运至血液中的情况相比,不同类型辅酶Q10产品的单剂量吸收进入淋巴的情况。

The Single-dose Absorption of Different CoQ10 Product Types Into the Lymph Compared to That Transported to the Blood.

作者信息

Judy William V

出版信息

Integr Med (Encinitas). 2022 Nov;21(5):30-35.

Abstract

CONTEXT

The science of the metabolism of CoQ10 before and after its absorption into the blood is well known. Almost nothing is known about the absorption of CoQ10 into the lymph.

OBJECTIVE

The study intended to measure and compare the single-dose absorption of three CoQ10 product formulations-crystal-free ubiquinone, crystalline ubiquinol, and a dry-powder ubiquinone-into the abdominal lymph duct as compared to their absorption into the blood circulation.

DESIGN

The researcher designed an animal study.

ANIMALS

The animals were six large dogs (>50 Kg).

INTERVENTION

By gastric gavage, the dogs were given a 100-mg dose of either crystal-free ubiquinone (Q-Best), crystalline ubiquinol (Qunol), or dry-powder ubiquinone, and lymph and venous samples (5 ml) were collected.

OUTCOME MEASURES

The primary end-point measurements for three CoQ10 product types were the concentration (Cmax), time of Cmax (Tmax), and total CoQ10 absorbed into the lymph and that transported to the blood.

RESULTS

Coenzyme Q10 (CoQ10) crystals were found in the dry powder and crystalline ubiquinol formulations. No crystals were found in the crystal-free formulation. Crystals from both the crystalline and dry-powder formulations were found in the small intestine's chyme. After ingestion of a 100-mg dose of CoQ10 formulation, the group mean absorption into the lymph peaked in 2 hours for all three formulations, and the peak appearance (Cmax) in the blood occurred at 6 hours. The absorption was significantly ( ≤ .001) greater for the crystal-free formulation compared to that of the crystalline and dry-powder formulations measured in the lymph and plasma.

CONCLUSIONS

These data show that the crystal-free formulation's absorption is superior to that found for the other two formulations. These results show that CoQ10 crystals are the causative factor for the poor absorption of CoQ10. The delayed appearance in the blood is due to the slow lymph flow delivering CoQ10 to the blood. The absorption of CoQ10 may not be as poor as described in the literature.

摘要

背景

辅酶Q10被吸收进入血液前后的代谢科学已为人熟知。而关于辅酶Q10被吸收进入淋巴的情况几乎一无所知。

目的

本研究旨在测量并比较三种辅酶Q10产品剂型——无定形泛醌、结晶型泛醇和干粉状泛醌——单剂量进入腹部淋巴管的吸收情况,并与它们进入血液循环的吸收情况进行比较。

设计

研究者设计了一项动物研究。

动物

实验动物为6只大型犬(体重>50千克)。

干预

通过胃管给犬灌胃100毫克剂量的无定形泛醌(Q-Best)、结晶型泛醇(Qunol)或干粉状泛醌,然后采集淋巴和静脉样本(5毫升)。

观察指标

三种辅酶Q10产品类型的主要终点测量指标为浓度(Cmax)、达到Cmax的时间(Tmax)以及吸收进入淋巴和转运至血液的辅酶Q10总量。

结果

在干粉状和结晶型泛醇剂型中发现了辅酶Q10(CoQ10)晶体。在无定形剂型中未发现晶体。在小肠食糜中发现了来自结晶型和干粉状剂型的晶体。摄入100毫克剂量的辅酶Q10剂型后,所有三种剂型进入淋巴的平均吸收量在2小时达到峰值,而血液中的峰值出现时间(Cmax)为6小时。与在淋巴和血浆中测得的结晶型和干粉状剂型相比,无定形剂型的吸收量显著更高(≤0.001)。

结论

这些数据表明,无定形剂型的吸收优于其他两种剂型。这些结果表明,辅酶Q10晶体是辅酶Q10吸收不良的致病因素。血液中出现延迟是由于淋巴流动缓慢将辅酶Q10输送到血液中。辅酶Q10的吸收可能并不像文献中描述的那么差。

相似文献

3
Bioavailability assessment of oral coenzyme Q10 formulations in dogs.
Drug Dev Ind Pharm. 2002 Nov;28(10):1195-200. doi: 10.1081/ddc-120015352.
4
The Plasma Bioavailability of Coenzyme Q Absorbed from the Gut and the Oral Mucosa.
J Funct Biomater. 2018 Dec 15;9(4):73. doi: 10.3390/jfb9040073.
7
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
Mitochondrion. 2007 Jun;7 Suppl:S78-88. doi: 10.1016/j.mito.2007.03.003. Epub 2007 Mar 27.
8
Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men.
Food Funct. 2018 Nov 14;9(11):5653-5659. doi: 10.1039/c8fo00971f.
9
Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.
Nutrition. 2019 Jan;57:133-140. doi: 10.1016/j.nut.2018.05.020. Epub 2018 Jun 27.
10
Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.
Clin Pharmacol Drug Dev. 2014 Jan;3(1):13-7. doi: 10.1002/cpdd.73. Epub 2013 Oct 8.

本文引用的文献

4
Bioavailability of Coenzyme Q: An Overview of the Absorption Process and Subsequent Metabolism.
Antioxidants (Basel). 2020 May 5;9(5):386. doi: 10.3390/antiox9050386.
5
Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.
Nutrition. 2019 Jan;57:133-140. doi: 10.1016/j.nut.2018.05.020. Epub 2018 Jun 27.
7
Relative bioavailability of two forms of a novel water-soluble coenzyme Q10.
Ann Nutr Metab. 2008;52(4):281-7. doi: 10.1159/000129661. Epub 2008 Jul 22.
8
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
Mitochondrion. 2007 Jun;7 Suppl:S78-88. doi: 10.1016/j.mito.2007.03.003. Epub 2007 Mar 27.
9
Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers.
Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28. doi: 10.1016/j.yrtph.2006.07.001. Epub 2006 Aug 21.
10
Bioavailability assessment of oral coenzyme Q10 formulations in dogs.
Drug Dev Ind Pharm. 2002 Nov;28(10):1195-200. doi: 10.1081/ddc-120015352.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验